PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease Reportshyperpigmentation
MeSH D017495 - hyperpigmentation
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D010859:Pigmentation disorders
0 Companies
0 Drugs
Success rate
D017495: 
Hyperpigmentation
$
Success rate
D008548:Melanosis
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaTretinoin Tretinoin  1998-06-19   
PadagisTretinoin Tretinoin  1998-12-24   
Taro PharmaceuticalTretinoin Tretinoin  2019-01-25   
Glenmark PharmaceuticalsTretinoin Tretinoin  2016-12-23   
MylanTretinoin Avita  1998-01-29   
Tretinoin Tretinoin  2013-07-17   
AlmirallTretinoin, Mequinol Solage  1999-12-10   
Clindamycin, Tretinoin Veltin  2010-07-16   
Bausch Health CompaniesTretinoin Renova  1995-12-29   
Tretinoin Retin-a  1982-01-01   
Clindamycin, Tretinoin Ziana  2006-11-07   
AllerganTretinoin Tretinoin  2010-03-22   
Clindamycin, Tretinoin Clindamycin Tretinoin  2015-06-12   
Barr PharmaceuticalsTretinoin Tretinoin  2007-06-22   
EndoTretinoin Tretinoin  2012-10-24   
1
2
>
Clinical Trials
Historical Success Rate
Phase 1
100%
2/2
Phase 2
0%
0/2
Phase 3
100%
1/1
Approved: 1Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
Bausch Health Companies
1
2
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use